Biohackhttps://biohack8.comLongevity and biohacking news, checked at the source.A daily pill for male hair loss passed its second big trial, maker sayshttps://biohack8.com/news/veradermics-oral-minoxidil-pill-second-phase-3-trial/https://biohack8.com/news/veradermics-oral-minoxidil-pill-second-phase-3-trial/Fri, 23 Oct 2026 12:01:35 GMTHair RestorationIn a six-month study of 536 men, a slow-release pill version of minoxidil, the active ingredient in Rogaine, grew more hair than a dummy pill. The results come from the company and have not been independently checked yet.A popular longevity supplement didn’t slow Parkinson’s in a large trialhttps://biohack8.com/news/nicotinamide-riboside-fails-early-parkinsons-phase-3-trial/https://biohack8.com/news/nicotinamide-riboside-fails-early-parkinsons-phase-3-trial/Fri, 23 Oct 2026 12:15:34 GMTSupplements & CompoundsIn a year-long study of 410 people with early Parkinson’s, the supplement nicotinamide riboside (NR) raised a molecule cells use for energy, but did not slow the disease. Symptoms got slightly worse than on a dummy pill.Drugmakers say Ozempic-style drugs slowed lab measures of aginghttps://biohack8.com/news/novo-lilly-glp1-drugs-aging-clocks-ardd-data/https://biohack8.com/news/novo-lilly-glp1-drugs-aging-clocks-ardd-data/Fri, 23 Oct 2026 12:04:22 GMTAnti-Aging ScienceNovo Nordisk and Eli Lilly told an aging conference that people taking semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) appeared to age more slowly on lab estimates of biological age. Nothing has been peer reviewed yet.Gene therapy that aims to make eye cells act younger is tried in 3 peoplehttps://biohack8.com/news/life-biosciences-er-100-first-human-glaucoma-data/https://biohack8.com/news/life-biosciences-er-100-first-human-glaucoma-data/Fri, 23 Oct 2026 12:03:51 GMTClinical TrialsThree people with glaucoma had no serious side effects in the eight weeks after a single eye injection, and two showed some improvement in their field of vision, Life Biosciences said. It is a very early, company-reported result.Alzheimer's drug tested in healthy people to see if it can prevent diseasehttps://biohack8.com/news/roche-trontinemab-alzheimers-prevention-trial-begins/https://biohack8.com/news/roche-trontinemab-alzheimers-prevention-trial-begins/Fri, 23 Oct 2026 15:22:42 GMTBrain Health & DementiaRoche's PrevenTRON study will give an experimental antibody or a placebo (a dummy treatment) to about 1,600 people aged 55 to 80 who have no memory problems but carry a blood marker linked to Alzheimer's.AI-designed lung drug made patients' blood look younger on 6 aging testshttps://biohack8.com/news/ai-designed-lung-drug-blood-younger-six-aging-clocks/https://biohack8.com/news/ai-designed-lung-drug-blood-younger-six-aging-clocks/Fri, 23 Oct 2026 15:12:03 GMTAI & LongevityIn 42 people with a scarring lung disease, six separate blood-protein aging tests all read younger on an experimental AI-designed drug. The split dose gave the steadiest signal, and the result is not proof it slows aging.One-time brain gene therapy for Huntington's is sent for US, UK approvalhttps://biohack8.com/news/uniqure-huntingtons-gene-therapy-us-uk-approval-filing/https://biohack8.com/news/uniqure-huntingtons-gene-therapy-us-uk-approval-filing/Fri, 23 Oct 2026 14:54:57 GMTGene & Cell TherapyuniQure has asked US and UK regulators to approve its one-time Huntington's gene therapy. The request rests on small early trials compared with untreated patients from outside the studies.